SERINC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.110810E-01
Normal-vs-Stage2
3.056800E-01
Normal-vs-Stage3
5.299400E-01
Normal-vs-Stage4
6.241900E-02
Stage1-vs-Stage2
5.876200E-01
Stage1-vs-Stage3
2.177600E-02
Stage1-vs-Stage4
7.318100E-02
Stage2-vs-Stage3
1.016990E-01
Stage2-vs-Stage4
1.826430E-01
Stage3-vs-Stage4
1.858380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.229400E-01
Normal-vs-AfricanAmerican
1.310200E-01
Normal-vs-Asian
6.514600E-01
Caucasian-vs-AfricanAmerican
4.356000E-01
Caucasian-vs-Asian
3.644800E-01
AfricanAmerican-vs-Asian
2.373800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.296400E-01
Normal-vs-Female
3.158800E-01
Male-vs-Female
7.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.867400E-01
Normal-vs-Age(41-60Yrs)
1.123600E-01
Normal-vs-Age(61-80Yrs)
4.614000E-01
Normal-vs-Age(81-100Yrs)
5.474200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.743000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.324600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.978800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.503050E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.129900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.923200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.151400E-01
Normal-vs-Daily Drinker
4.359800E-01
Normal-vs-Weekly Drinker
5.627200E-01
Normal-vs-Occasional Drinker
1.203650E-01
Normal-vs-Social Drinker
3.637600E-01
Non Drinker-vs-Daily Drinker
3.043400E-01
Non Drinker-vs-Weekly Drinker
8.788200E-01
Non Drinker-vs-Occasional Drinker
6.259200E-03
Non Drinker-vs-Social Drinker
2.114800E-01
Daily Drinker-vs-Weekly Drinker
4.898200E-01
Daily Drinker-vs-Occasional Drinker
5.771600E-02
Daily Drinker-vs-Social Drinker
6.384000E-01
Weekly Drinker-vs-Occasional Drinker
1.895550E-02
Weekly Drinker-vs-Social Drinker
2.922000E-01
Occasional Drinker-vs-Social Drinker
2.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.624800E-01
Normal-vs-Grade 2
1.334420E-01
Normal-vs-Grade 3
1.111160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.134600E-01
Grade 1-vs-Grade 3
1.451610E-01
Grade 1-vs-Grade 4
3.624800E-01
Grade 2-vs-Grade 3
1.987210E-01
Grade 2-vs-Grade 4
1.334420E-01
Grade 3-vs-Grade 4
1.111160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.754600E-01
Normal-vs-NonDiabetic
3.423800E-01
Diabetic-vs-NonDiabetic
3.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.595600E-01
Normal-vs-NoPancreatitis
3.577000E-01
Pancreatitis-vs-NoPancreatitis
8.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.892200E-01
Normal-vs-N1
3.123400E-01
N0-vs-N1
8.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.477620E-01
Normal-vs-TP53-NonMutant
4.004000E-01
TP53-Mutant-vs-TP53-NonMutant
7.321900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
